Di Renzo Regulatrory Affairs

Regulatory Affairs & Life Science

Business EN ↓ 38 episodes

The Di Renzo Regulatory Affairs podcast for pharmaceutical companies, for manufacturers of medical devices, cosmetics, food supplements and disinfectants. News from our blog and from our weekly magazine ISI, Information Health.

Be sure to visit the podcast's website and support the creator: www.direnzo.biz

Author

Di Renzo Regulatrory Affairs

Category

Business

Podcast website

www.direnzo.biz

Latest episode

Oct 16, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

PPWR (EU 202540) Obligations, Deadlines & Exemptions for Industry 16.10.2026

The new EU Packaging and Packaging Waste Regulation (PPWR) 2025/40 has introduced stringent rules across the entire supply chain. But what does it mean in practice for highly regulated industries? In this episode, we break down the impact of the PPWR on: Pharmaceuticals (human & veterinary) and primary packaging exemptions Medical Devices & IVDs: eco-design, UDI labeling, and secondary pac...

Medical Devices and IVD in Spain: introduction to the RECOPS database 18.09.2026

In the regulatory landscape of medical devices in Europe, Spain is introducing significant updates. In this episode, we clarify the transition that led to the decommissioning of the old CCPS database and the introduction of the new RECOPS portal (Registro de comercialización de productos sanitarios) by AEMPS. We will analyze what changes for manufacturers and economic operators, the fundamental li...

AI and Promotional Materials in the Pharma Sector: The New AIFA Guidelines 07.09.2026

Generative Artificial Intelligence is transforming the way pharmaceutical companies create content and scientific information. But how can technological innovation be reconciled with the current regulatory framework? In this new podcast episode, we analyze the recent AIFA Guidelines published by the Drug Information and Advertising Vigilance Unit. What we cover in this episode: Responsibility rema...

Biocides and Co-formulants: How to Prepare for ECHA’s New Guidance 24.07.2026

The European Chemicals Agency (ECHA) has released a new draft guidance dedicated entirely to the identification and assessment of Substances of Concern (SoC) in biocidal products under the Biocidal Products Regulation (BPR - Regulation EU No 528/2012).In this episode, we break down this major regulatory update and what it means for the chemical and manufacturing industries.

MDR Turning Point: What Changes with the Proposed Revision of the Medical Device Regulation? 14.07.2026

A few years after the entry into force of Regulation (EU) 2017/745 (MDR), the European Commission is taking action to make the system more sustainable. With the amendment proposal COM(2025)1023 , Europe aims to cut red tape and boost the competitiveness of the medical sector—without compromising the strict safety standards of medical devices. In this podcast episode, we analyze the impact of this...

EUDAMED and UDI Codes: A Practical Guide to Getting It Right 03.07.2026

As deadlines approach and new European obligations take effect, the proper management of medical devices requires unprecedented attention. In this episode, we clear up everything you need to know to successfully navigate EUDAMED registration (registrazione eudamed) without running into compliance roadblocks. We will break down the system's operational phases, explaining how to structure your data...

Importers and Distributors: When Do Manufacturers' Obligations Start? (MDR/IVDR) 25.05.2026

When does a distributor or importer become, for all legal purposes, the MANUFACTURER of a medical device? In this episode, we shed light on one of the most complex, sensitive, and controversial aspects of the European Regulation on Medical Devices (MDR 2017/745) and the European Regulation on In Vitro Diagnostics (IVDR 2017/746): Article 16 . If you work in logistics, distribution, import, or comp...

The importance of GMP audits for the production of "Human" and "Vet" pharmaceuticals 22.05.2026

What happens before a drug reaches our hands or those of our animals? In this episode, we explore the beating heart of safety and compliance: GMP (Good Manufacturing Practice) audits in the pharmaceutical industry. Together with industry professionals, we analyze why these inspections aren't just bureaucratic procedures, but rather true safeguards for public health and business stability. We'll di...

Drug Shortages: What changes for MAH holders? 💊 20.03.2026

Managing shortages is more than just a logistical challenge; it is a complex web of regulatory obligations. In this episode, we analyze the latest AIFA (Italian Medicines Agency) provisions and the specific responsibilities of Marketing Authorization Holders (MAH).In this episode, we dive into: Mandatory communication timelines and procedures. Penalties for failure to notify. Operational strategie...

AIFA guidelines for SOP and OTC 06.03.2026

Managing SOP ( Non-Prescription Medicines ) and OTC (Over-the-Counter) drugs requires surgical attention to regulatory details. In this episode, we explore the key points of the AIFA guidelines: ✅ Medicine classification.  ✅ Requirements for online sales. ✅ Sticker layouts and mandatory labeling. An essential episode for Regulatory Affairs Managers and industry consultants. Enjoy the listen!

Packaging & Compliance: Why Design Alone Isn’t Enough 06.02.2026

In the Pharma and Healthcare sectors, a graphic error is more than just an aesthetic flaw—it’s a significant legal risk. In this episode, we analyze why the design of pharmaceuticals, supplements, and medical devices must go hand-in-hand with Regulatory Affairs .Join our experts as we explore: Pharmaceutical Sector: Managing artwork and the surgical precision required for patient information leafl...

The New Face of Veterinary GMPs 02.02.2026

The veterinary medicinal products sector is undergoing an unprecedented regulatory transformation. In this episode, we analyze the adaptation to the new veterinary GMPs (Good Manufacturing Practices) introduced by Regulation (EU) 2019/6 and subsequent directives. We explore the key points from the article by Di Renzo Regulatory Affairs , focusing on: The primary differences compared to standards f...

ACC System: The New Rules for "Intermediate Dates" 26.01.2026

Description: In this episode, we analyze the recent technical updates to the Conventions and Congresses Authorization System (ACC) , effective January 19 . The introduction of the "Intermediate Dates" field is more than just a software update; it is a new procedural requirement impacting compliance for pharma companies and providers. Join the experts at Di Renzo Regulatory Affairs as we dive into:...

What are orphan drugs? 02.12.2025

Developing Orphan Drugs is a true undertaking! 🧐 In our latest episode, we dive deep into the market challenge for pharmaceutical companies and the crucial role of the European Regulation (EC 141/2000). Discover how the 'Orphan Drug' designation and incentives are changing the lives of patients with rare diseases. Don't miss it! 👇 https://en.direnzo.biz/orphan-drugs-description/ OrphanDrugs #Pha...

EUDAMED Countdown: Are You Ready for the 2026 UDI Mandate? 28.11.2025

🗓️ Starting 28 May 2026, UDI registration in EUDAMED will become mandatory for all medical devices marketed in the EU. What does this mean for manufacturers, importers and Regulatory Affairs professionals? Find out in the new episode as we break down deadlines, obligations and the practical impact of the latest EU decisions.

EMA PMS Update: Navigating the New Era of Product Data 12.11.2025

New podcast episode out now! Let’s dive into the latest updates from the European Medicines Agency (EMA) on the Product Management Service (PMS) database — key changes on the XEVMPD migration, deadlines, ISO-IDMP requirements, and their impact on MAHs. A must-listen for professionals in regulatory affairs across pharma. Don’t miss it! #regulatoryaffairs #PMS #EMA #pharma #regulatoryconsulting

Biocides in 2025 New Rules, New Responsibilities 03.10.2025

In this episode, we clarify the transition from Directive 98/8/EC to Regulation (EU) 528/2012 (BPR) , the European framework that regulates the placing on the market and use of biocidal products. We’ll explore the differences between the Directive and the Regulation, the role of PMCs in Italy, and the new obligations for businesses. Step by step, we will discuss how to obtain authorization, ensure...

MIR 7.3.1: Everything Manufacturers Need to Know Before November 2025 19.09.2025

The new version of the Manufacturer Incident Report ( MIR 7.3.1 ) is now available and will become mandatory in the EU and Switzerland starting November 2025 for the reporting of serious incidents involving medical devices and IVDs. In this episode we cover: the main updates (new fields, IMDRF codes, geographical and technical changes); key differences from the previous version; what manufacturers...

Pharmacovigilance Goes Social 12.09.2025

Social media isn’t just about likes and shares anymore—it’s becoming a powerful tool in pharmacovigilance. In this episode of Regulatory Affairs & Life Science, we dive into how online conversations can reveal valuable insights about drug safety and real patient experiences . Join us as we explore: why social networks are a game-changer for collecting safety data, the regulatory and practical...

Classification of medical devices in Italy 21.08.2025

In this episode, we explore the essentials of medical device registration under Italian law and the EU Medical Device Regulation (MDR 2017/745). We cover everything you need to know about the Italian medical device database, the Repertorio, the CND classification system, and the future role of EUDAMED. 🔑 Keywords & Topics: Medical device registration process Italian Ministry of Health require...

Top Registration Mistakes That Could Cost Your Medical Device Approval 30.07.2025

In this episode, we examine the most frequent mistakes made by companies and economic operators during the registration of medical devices. From selecting the correct UDI code to properly designating the economic operator, we provide a clear and practical overview of the key issues to avoid in order to ensure a compliant and effective registration process. A valuable episode for industry professio...

Local pharmacovigilance: all requirements, how to be compliant 25.07.2025

Welcome to a new episode of the Di Renzo Regulatory Affairs podcast, where we explore key topics from the world of pharmaceutical regulatory affairs — with clarity, professionalism, and a practical approach. Today, we’re focusing on a crucial subject for all Marketing Authorisation Holders: Local Pharmacovigilance . It’s a vital system to ensure patient safety and regulatory compliance — often und...

Is our software a Medical Device? 02.07.2025

In this episode of the Di Renzo Regulatory Affairs Podcast, we explore a question at the heart of digital health compliance: When does your software become a medical device? Drawing from our latest article “ How to understand if the software is a medical device? ” we dissect the critical concept of intended medical purpose—diagnosis, prevention, monitoring, or treatment—and how it transforms stand...

Labelling pharmaceutical sectors 10.06.2025

Join us in this episode as we delve into the complex world of medicinal product labelling —a cornerstone of patient safety and regulatory compliance. We’ll explore: Evolving EU requirements: product names, active substances, strengths, and routes of administration; The impact of 2D QR codes and Braille: innovations for inclusive and accessible communication; The regulatory evolution of multilingua...

Are our cosmetics labels compliant 30.05.2025

🎙️ New episode of the Di Renzo Regulatory Affairs podcast! Today we’re diving into a topic that is often underestimated but absolutely essential in the cosmetics sector: labeling. 📦 What does a label need to include to be considered compliant? 🧴 Which pieces of information are mandatory, and what mistakes should be avoided at all costs? In this episode, our experts walk you through the 7 key rul...

Listen to the Regulatory Affairs & Life Science podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.